
Cardiologist

No OPD information available
Heart Attack
Acute Coronary Syndrome
Angina
Coronary Heart Disease
Angioplasty
Arteriovenous Malformation
Atrial Fibrillation
Calcinosis
Cardiac Ablation
Chronic Kidney Disease
Congenital Coronary Artery Malformation
Coronary Artery Spasm
Heart Tumor
Hypertension
Kidney Transplant
Obstructive Sleep Apnea
Percutaneous Coronary Intervention (PCI)
Stable Angina
Stroke
Vasoconstriction
Matthew I. Worthley is a male healthcare provider who helps patients with various heart-related issues like heart attacks, angina, and high blood pressure. He also treats conditions like kidney disease, sleep apnea, and strokes. Matthew is skilled in procedures like angioplasty and cardiac ablation to improve heart health.
Patients trust Matthew because he communicates clearly and listens to their concerns. He explains treatments in a way that is easy to understand, which helps patients feel more comfortable and confident in their care. Matthew stays updated with the latest medical research to provide the best possible treatments for his patients.
Matthew works well with other medical professionals, collaborating to ensure patients receive comprehensive care. His positive relationships with colleagues contribute to a supportive and effective healthcare team. Matthew's dedication to teamwork helps improve patient outcomes and overall quality of care.
Matthew's work has had a positive impact on many patients' lives. Through his expertise and compassionate care, he has helped patients manage chronic conditions, recover from serious illnesses, and improve their overall health and well-being. His research on chronic coronary syndromes and participation in clinical trials for diabetes treatments demonstrate his commitment to advancing medical knowledge and improving patient outcomes.
In summary, Matthew I. Worthley is a caring and skilled healthcare provider who prioritizes patient well-being and stays current with medical advancements to deliver high-quality care. His collaborative approach with colleagues and dedication to research contribute to positive outcomes for his patients.
Enrollment Status: Active not recruiting
Published: February 28, 2025
Intervention Type: Drug
Study Drug:
Study Phase: Phase 3
